Professor Tony Kouzarides, a co-founder of online catalogue-based antibodies distributor Abcam, has sold more than one-quarter of his shareholding.
Professor Kouzarides sold 29,000 shares at 1187p each. That is just below the all time high of 1259p a share. He is left with 85,244 shares.
Abcam floated at 167p a share in November 2005.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Cambridge-based Abcam's sales in the six months to December 2009 jumped 37.8% to £31.8m from £23.1m the year before, or by 25.3% on a constant currency basis.
Profit before tax surged 64% to £11.2m from £6.8m as the company increased its range of products from 47,870 at the end of 2008 to 57,960 at the end of 2009.
Net cash was £33m at the end of 2009. The company doubled its interim dividend to 5.42p a share and this was paid on 1 April.
Top Director Buys
Emerging Metals (EML) Director name: Mr James MellonAmount purchased: 2,000,000 @ 8.9625p Value: £179,250
Antofagasta (ANTO) Director name: Mr Ramon JaraAmount purchased: 1,260 @ 1072p Value: £13,507
Top Director Sells
Abcam (ABC) Director name: Prof Tony Kouzarides Amount purchased: 29,000 @ 1187p Value: £344,230
Group NBT (NBT) Director name: Mr Keith YoungAmount purchased: 50,000 @ 315p Value: £157,500
-
FTSE 100 hits record highs – why is it rising and will we see more gains?Advice UK equities have been described as unloved for a long time but as the FTSE 100 hits new highs, we explain if now is the time to buy British.
-
How to invest in copperIt may be time to invest in copper as the red metal appears poised for a big jump. Dominic Frisby looks at what should investors should buy
